spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  rosiglitazone maleate 

 HSMN NewsFeed - 14 Jul 2008
FDA Updates Label for AVANDIA(R) to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 8 Apr 2008
GlaxoSmithKline Confirms Receipt of FDA Letter on Regulatory Reporting
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Dec 2007
GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
Biopharmaceuticals Endocrinology Cardiology
 HSMN NewsFeed - 14 Nov 2007
GSK Revises US Labeling for Avandia(R)
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 27 Sep 2007
Teva Announces Settlement of Generic Avandia(R), Avandamet(R), and Avandaryl(R) Litigation with GlaxoSmithKline
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 11 Sep 2007
GlaxoSmithKline Responds to JAMA Articles
Biopharmaceuticals Endocrinology Cardiology
 HSMN NewsFeed - 14 Aug 2007
GlaxoSmithKline Updates Prescribing Information for Avandia
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 31 Jul 2007
FDA Advisory Panel Votes 22 to 1 for Avandia(R) to Remain Available to Patients in the US
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 30 Jul 2007
GlaxoSmithKline Presents Avandia Data To FDA
Biopharmaceuticals Endocrinology Cardiology FDA
 HSMN NewsFeed - 11 Jul 2007
Adnexus Therapeutics Appoints Martin Freed, MD as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jun 2007
New Data Show Patients Treated With Avandia(R) (Rosiglitazone Maleate) Incurred Lower Medical Costs and Used Fewer Healthcare Resources When Compared to Patients Treated With Sulphonylureas
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 6 Jun 2007
Newly Published Data From Large Study Support Cardiovascular Safety of Avandia (rosiglitazone maleate)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 30 May 2007
Data Affirms Avandia (Rosiglitazone maleate) Cardiovascular Safety Profile
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 21 May 2007
GlaxoSmithKline Responds to NEJM Article on Avandia
Biopharmaceuticals Endocrinology Cardiology
 HSMN NewsFeed - 4 Dec 2006
Landmark Study Shows Avandia(R) (rosiglitazone maleate) Is More Effective Than Metformin or a Sulfonylurea in Long-Term Blood Sugar Control in Type 2 Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 15 Sep 2006
Avandia(R) (rosiglitazone maleate) Reduced Risk of Progression From Pre-Diabetes To Type 2 Diabetes by 62 Percent in Largest Completed Diabetes Prevention Trial
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 11 Jul 2006
GlaxoSmithKline Announces FDA Approval and the Launch of Avandamet(R) (Rosiglitazone Maleate and Metformin HCl) as Initial Therapy in the Treatment of Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA
Return to NewsFeed  

 Additional items found! 14

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 14 additional stories matching:
rosiglitazone maleate
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!